Suppr超能文献

需要全胃肠外营养和肌松剂的婴儿在心脏移植时经历较差的移植后死亡率。

Infants Who Require Total Parenteral Nutrition and Paralytics at Time of Heart Transplant Experience Inferior Post-Transplant Mortality.

机构信息

The Heart Institute, 2518Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

出版信息

World J Pediatr Congenit Heart Surg. 2022 Nov;13(6):752-758. doi: 10.1177/21501351221119495.

Abstract

Infants experience the worst one-year post-heart transplant (HTx) survival of any other pediatric group. Although mechanical ventilatory (MV) requirement at the time of transplant is an established predictor of post-transplant mortality, the impacts of commonly co-utilized support modalities such as total parenteral nutrition (TPN)-dependence and paralytics are understudied. All infant HTx recipients from 2003 to 2020 in both the United Network for Organ Sharing and Pediatric Health Information System databases were identified (n = 1344) and categorized depending upon requirement at the time of transplant-none (59%), MV-only (10%), MV + Paralytics (2%), TPN-dependence-only (15%), MV + TPN (10%), and MV + Paralytics + TPN (4%). The primary study aim was to characterize the impact of TPN-dependence and paralytics on one-year post-transplant survival (PTS). Compared to no-support, infants were generally at higher risk and more ill at transplant, with greater rates of congenital heart disease, renal and hepatic dysfunctions, and inotrope requirements. Post-transplant hospital outcomes were inferior among patients; all groups experienced longer post-transplant MV, intensive care unit, and hospital lengths of stay (all  < .05 vs no-support). Upon multivariable analysis, each modality independently predicted 1-year mortality (MV vs no-MV: 1.54 [1.10-2.14]; MV + Paralytics vs neither: 2.02 [1.25-3.27]; TPN vs no-TPN: 1.53 [1.10-2.13];  < .01 for all), whereas no-support was protective (HR 0.66 [95% CI 0.48-0.91]). Infants who require paralytics and/or who are TPN-dependent at the time of HTx experience worse one-year PTS. Such knowledge can assist in risk-stratification, and the identification of patients who would benefit from pretransplant optimization.

摘要

婴儿在心脏移植(HTx)后一年的生存率是所有儿科群体中最差的。尽管在移植时需要机械通气(MV)是移植后死亡率的既定预测因素,但通常共同使用的支持方式的影响,如全胃肠外营养(TPN)依赖和肌松剂的影响,研究得还不够充分。在美国器官共享联合网络和儿科健康信息系统数据库中,确定了 2003 年至 2020 年间所有婴儿 HTx 受者(n=1344),并根据移植时的需求进行分类-无(59%)、仅 MV(10%)、MV+肌松剂(2%)、仅 TPN 依赖(15%)、MV+TPN(10%)和 MV+肌松剂+TPN(4%)。主要研究目的是描述 TPN 依赖和肌松剂对移植后一年生存率(PTS)的影响。与无支持相比,婴儿在移植时通常风险更高,病情更严重,患有先天性心脏病、肾功能和肝功能障碍以及儿茶酚胺需求的比例更高。移植后住院结局较差;所有组经历了更长的移植后 MV、重症监护病房和住院时间(均 < .05 与无支持相比)。多变量分析显示,每种方式均独立预测 1 年死亡率(MV 与非 MV:1.54 [1.10-2.14];MV+肌松剂与两者均无:2.02 [1.25-3.27];TPN 与非 TPN:1.53 [1.10-2.13];所有 < .01),而非支持具有保护作用(HR 0.66 [95% CI 0.48-0.91])。在 HTx 时需要肌松剂和/或 TPN 依赖的婴儿,1 年 PTS 较差。这种知识可以帮助进行风险分层,并确定受益于移植前优化的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验